Summa Health System

1. CSL Behring $466,185 37 payments
2. Abbott Laboratories $184,285 36 payments
3. Boston Scientific Corporation $102,790 67 payments
4. NuVasive, Inc. $68,661 20 payments
5. Biogen, Inc. $39,026 4 payments
6. Globus Medical, Inc. $37,074 12 payments
7. Grifols Therapeutics LLC $36,268 4 payments
8. Gilead Sciences, Inc. $25,039 16 payments
9. Corcept Therapeutics $21,655 7 payments
10. Celgene Corporation $16,357 8 payments

1. A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra / Beriplex]) to Improve Survival in Patients With Traumatic Injury and Acute Major Bleeding $454,202 29 payments
2. Hemodynamic-GUIDEd Management of Heart Failure $86,412 8 payments
3. Asap Too $69,452 33 payments
4. NUVA.CIB0420: A prospective, multicenter study evaluating the safety and performance of interbody implants for the treatment of patients with degenerative conditions of the cervical spine $64,779 20 payments
5. A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin IVIG Plus Standard Medical Treatment SMT Versus SMT Alone in Subjects With COVID-19 Requiring Admission to the In $36,268 4 payments
6. Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) $35,905 7 payments
7. A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Cervical Spine $26,187 4 payments
8. Cort125134-552 $21,655 7 payments
9. Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction $21,456 1 payment
10. Hemodynamic-GUIDEd Management of Heart Failure $21,217 8 payments

1. Patient care $4,221 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.